LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,321,000 | -89.7% | 8,000 | -91.5% | 0.01% | -90.0% |
| Q4 2017 | $12,859,000 | -38.5% | 93,916 | -38.9% | 0.06% | -43.9% |
| Q3 2017 | $20,915,000 | +157.9% | 153,614 | +130.0% | 0.11% | +127.7% |
| Q2 2017 | $8,109,000 | +82.7% | 66,800 | +59.3% | 0.05% | +30.6% |
| Q1 2017 | $4,439,000 | -61.9% | 41,941 | -63.4% | 0.04% | -56.6% |
| Q4 2016 | $11,646,000 | +206.0% | 114,622 | +207.3% | 0.08% | +196.4% |
| Q3 2016 | $3,806,000 | +108.5% | 37,300 | +143.8% | 0.03% | +100.0% |
| Q2 2016 | $1,825,000 | +748.8% | 15,300 | +665.0% | 0.01% | +1300.0% |
| Q1 2016 | $215,000 | -69.0% | 2,000 | -75.3% | 0.00% | -66.7% |
| Q3 2015 | $694,000 | -93.4% | 8,100 | -92.2% | 0.00% | -95.2% |
| Q2 2015 | $10,534,000 | +53.2% | 104,400 | +17.0% | 0.06% | +21.2% |
| Q1 2015 | $6,878,000 | – | 89,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |